EUVIMEDEUVIMED entdecken
Open Access

The Current and Future Burden of Long COVID in the United States

Sarah M Bartsch, Kevin L Chin iD, Ulrich Strych, Danielle C John, Tej D Shah iD, Maria Elena Bottazzi, Kelly J O'Shea, McKaylee Robertson iD, Colleen Weatherwax iD, Jessie Heneghan, Marie F Martinez, Allan Ciciriello und 8 weitere

The Journal of Infectious Diseases · 11.07.2025 · 231 (6) · 1581-1590

DOI: 10.1093/infdis/jiaf030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 22.01.2025. Verfasst von Sarah M Bartsch und 19 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Informatics, Computational, and Operations Research, City University of New York Graduate School of Public Health and Health Policy, Ne…. Hauptthemen laut MEDLINE: COVID-19, Cost of Illness. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, City University of New York.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long coronavirus disease (COVID), which affects an estimated 44.69–48.04 million people in the United States, is an ongoing public health concern that will persist as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread.

Methods

We developed a computational simulation model representing the clinical course, health effects, and associated costs of a person with long COVID.

Results

Simulations show that the average total cost of a long COVID case can range from $5084–$11 646 (assuming symptoms only last 1 year) with 92.5%–95.2% of these costs being productivity losses. Therefore, the current number of long COVID cases could cost society at least $2.01–$6.56 billion, employers at least $1.99–$6.49 billion in productivity losses, and third-party payers $21.0–$68.5 million annually (6%–20% probability of developing long COVID). These cases would accrue 35 808–121 259 quality-adjusted life-years (QALYs) lost and 13 484–45 468 disability-adjusted life-years (DALYs) and would rise as COVID-19 incidence increases.

Conclusions

The current health and economic burden of long COVID may already exceed that of a number of other chronic diseases and will continue to grow each year as COVID-19 cases increase. This could be a significant drain on businesses, third-party payers, the healthcare system, and society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cost of IllnessHumansUnited StatesSARS-CoV-2Computer SimulationHealth Care CostsPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

costeconomiclong COVIDmodelpost-COVID conditions

Autor:innen und Institutionen

  • Public Health Informatics, Computational, and Operations Research, City University of New York Graduate School of Public Health and Health Policy, New York City, New York, USA.
  • Center for Advanced Technology and Communication in Health, City University of New York Graduate School of Public Health and Health Policy, New York City, New York, USA.
  • Artificial Intelligence, Modeling, and Informatics for Nutrition Guidance and Systems Center, City University of New York Graduate School of Public Health and Health Policy, New York City, New York, USA.
  • Department of Pediatrics, and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Pandemic Response Institute, New York City, New York, USA.
  • Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Kevin L Chin, Tej D Shah, McKaylee Robertson, Colleen Weatherwax, Alexis Dibbs, Sheryl A Scannell, Yanhan Shen, Denis Nash, Peter J Hotez

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • City University of New York
  • US Department of Health and Human Services
  • National Institutes of Health

Zitieren

APA

Bartsch, S. M., Chin, K. L., Strych, U., John, D. C., Shah, T. D., Bottazzi, M. E., O'Shea, K. J., Robertson, M., Weatherwax, C., Heneghan, J., Martinez, M. F., Ciciriello, A., Kulkarni, S., Velmurugan, K., Dibbs, A., Scannell, S. A., Shen, Y., Nash, D., Hotez, P. J., & Lee, B. Y. (2025). The Current and Future Burden of Long COVID in the United States. The Journal of Infectious Diseases, 231(6), 1581-1590. https://doi.org/10.1093/infdis/jiaf030

Vancouver

Bartsch SM, Chin KL, Strych U, John DC, Shah TD, Bottazzi ME, et al. The Current and Future Burden of Long COVID in the United States. The Journal of Infectious Diseases. 2025;231(6):1581-1590. doi:10.1093/infdis/jiaf030

BibTeX
@article{Bartsch2025,
  author = {Bartsch, Sarah M and Chin, Kevin L and Strych, Ulrich and John, Danielle C and Shah, Tej D and Bottazzi, Maria Elena and O'Shea, Kelly J and Robertson, McKaylee and Weatherwax, Colleen and Heneghan, Jessie and Martinez, Marie F and Ciciriello, Allan and Kulkarni, Sarah and Velmurugan, Kavya and Dibbs, Alexis and Scannell, Sheryl A and Shen, Yanhan and Nash, Denis and Hotez, Peter J and Lee, Bruce Y},
  title = {The Current and Future Burden of Long COVID in the United States},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {6},
  pages = {1581--1590},
  doi = {10.1093/infdis/jiaf030}
}
Kostenlos starten →